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INTRODUCTION
Intractable diarrhea of infancy”was first described by
Avery et al. (1) as a non-infectious diarrhea lasting for more
than 2 weeks, with onset before 3 months of age, with con-
sequent malabsorption and failure to thrive. The definition
and outcome of intractable diarrhea have changed consider-
ably during the last two decades because of a better under-
standing of the pathology of the small bowel mucosa and
major improvements in nutritional management. The term
“intractable diarrhea of infancy” embraces a heterogeneous
syndrome with a diverse etiology. By “protracted diarrhea
(PD) in early childhood,” we allude to children whose diar-
rhea start within the first 2 yr of life, becomes life threaten-
ing, and leads to dependence on parenteral nutrition (PN)
for at least two weeks (2). Several chronic enteropathies that
may be responsible for intractable diarrhea have been descri-
bed. These include congenital microvillous atrophy or micro-
villous inclusion disease (3), tufting enteropathy (4), and
other ultrastructural abnormalities of the enterocyte (5), and
autoimmune enteropathy (6). Despite recent advances, PD
still represents a daunting problem for the pediatric gastroen-
terologist. It is also becoming a major problem because of
its high impact on health care resources.
An attempt to classify intractable diarrhea according to
villous atrophy made on the basis of immunohistological
and clinicopathologic criteria (7-9). In this study we made a
modified application of these classifications and character-
ized the spectrum of causes and clinical manifestations of
this diarrheal syndrome in the patients admitted to a ter-
tiary hospital in Korea.
MATERIALS AND METHODS
Patients
Thirty-six cases recruited in this study included all pa-
tients who had been admitted to the Department of Pedi-
atrics, Samsung Medical Center during a 5-yr period (March
1, 1996 through Feb 28, 2001). Of these 36 cases, 25 ful-
filled the following criteria; age less than 2-yr at the onset
of diarrhea, diarrhea lasting more than 2 weeks, unrespon-
sive to hypoallergenic milk, and need for PN to provide at
least 50% of the daily energy intake for a minimum of 2
weeks’ duration. Children with anatomic abnormalities of
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Protracted Diarrhea: Results of the Five-year Survey in a Tertiary
Hospital in Korea
The syndrome of protracted diarrhea (PD) includes several diseases with diverse
etiologies. This study was conducted to characterize the spectrum of causes,
clinical manifestations, and the outcomes of PD. A retrospective analysis of the
clinical and pathological findings was performed on 25 patients with diarrhea
starting within the first 2 yr of life and a requirement of parenteral nutrition (PN).
According to the intestinal histopathology, patients were classified into four
groups: immune enteropathy (12 cases), lymphangiectasia (6 cases), epithelial
dysplasia (5 cases), and unclassified (2 cases). All patients with epithelial dyspla-
sia had earlier onset of diarrhea and longer duration of PN than those in the other
groups. Three patients (12%) had an evidence of a familial condition. Five
patients (three with microvillous inclusion disease and two with immune
enteropathy) died. Sixteen patients recovered, and three (two with primary lym-
phangiectasia and one with microvillous inclusion disease) still had diarrhea. One
patient underwent intestinal transplantation for tufting enteropathy. In conclusion,
infants with PD should be referred to specialized centers where advanced diag-
nostic and therapeutic facilities are available, because histological analysis is crit-
ical for the diagnosis of PD, and PN or intestinal transplantation is the only thera-
peutic option in a subset of cases.
Key Words : Diarrhea; Autoimmune Enteropathy; Microvilli; Epithelial Dysplasia; Lymphangiectasis;
Intestine, Small; Mucosal Histology
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the gut, congenital or acquired immunodeficiency syndromes,
or congenital carbohydrate malabsorption (e.g., glucose-galac-
tose malabsorption) were excluded from the study.
Methods
The clinical data were collected in each case and included
family history, time of symptom onset (Fig. 1), treatment,
and outcome. The results of the following investigations were
obtained in each case: routine blood tests, fecal-reducing
substances, occult blood,  1-antitrypsin stool excretion,
stool cultures (for Salmonella, Shigella, Campylobacter jejuni,
and Yersinia enterocolitica), and virus analysis (Rotavirus).
All patients were given duodenoscopy for a small intesti-
nal biopsy for histology and electron microscopy. One to
seven biopsies were performed in each patient. Light and
electron microscopic analysis included the degree of villous
atrophy (mild, moderate, or severe); crypt appearance (hyper-
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Fig. 1. (A) The histology of immune enteropathy shows moderate villous atrophy with crypt hyperplasia and increased cellularity of the
lamina propria and an increased number of intraepithelial lymphocytes and eosinophils (H&E, ×100). (B) The histology of epithelial
dysplasia shows normal intestinal villi with abnormal epithelium showing focal disorganization and crowding of surface enterocytes
forming tufts (H&E, ×100). (C) The histology of lymphangiectasia shows dilated lymphatics in the intestinal mucosa (H&E, ×100). (D)
Electron micrograph of microvillous inclusion disease shows the surface epithelium containing a membrane bound inclusion lined by
microvilli (×2,500, Bar represents 4  m).738 N.S. Beck, I.-S. Kang, Y.-L. Suh
plasia or normal); epithelial cell appearance (an epithelial
cell tuft was defined as a focal crowding and disorganization
of surface enterocytes); the mononuclear cellularity of the
lamina propria; the density of intraepithelial lymphocytes;
an increased number of eosinophils either in the epithelium
or in the lamina propria; and appearance of microvilli and
the presence of microvillous inclusions. According to the
histologic findings, cases were grouped as follows, with a
modification of the methods used in the previous studies (7-
9); immune enteropathy group, epithelial dysplasia group,
lymphangiectasia group, and unclassified group. Immune
enteropathy was defined as moderate to severe villous atro-
phy with significant crypt hyperplasia (8, 9) and an increased
number of eosinophils either in the epithelium or in the
lamina propria. Epithelial dysplasia was defined as normal
to moderate villous atrophy with dysplastic epithelium such
as congenital microvillous atrophy, dystrophy, microvillous
inclusion, or tufting enteropathy (4, 5, 10, 11). Lymphang-
iectasia was defined as lymphangiectatic intestinal histolog-
ic findings accompanied with protein losing enteropathy
without any proven causes (Fig. 1).
RESULTS
The clinical features and outcomes of 25 children enrolled
in the study are shown in Table 1. There were 12 boys (48
%) and 13 girls (52%) whose mean age of onset was 7.2±
7.7 months (range: 1 day-2 yr). The distribution of diarrhea
onset age is shown in Fig. 2. Twelve cases belonged to the
immune enteropathy group and six patients were classified
into the lymphangiectasia group. The epithelial dysplasia
group included five patients: four patients with microvillous
inclusion disease and one with tufting enteropathy. Two cases
remained unclassified and showed normal to mild villous
atrophy without significant dysplastic epithelium.
Diarrhea started between 1 day and 24 months of age
(median=89 days). All five cases included in the epithelial
Age (day) Sex Group Patients Diagnosis
TPN duration 
(day)
Villous atrophy 
(grade)
Outcome
1 1 F ED MVID 28 1 expired
2 1 M ED MVID 33 1 expired
3 4 M ED MVID 152 2 persistent diarrhea
4 1 F ED MVID 61 2 expired
5 4 F ED Tufting enteropathy 360 1 IT
6 22 F IE 15 2 recovered
7 120 F IE 17 2 recovered
8 360 F IE 16 2 recovered
9 457 F IE 15 2 recovered
10 358 M IE 18 2 recovered
11 60 F IE 30 2 recovered
12 62 F IE 34 2 recovered
13 90 M IE 27 3 recovered
14 25 M IE 124 3 recovered
15 89 F IE 118 3 expired
16 65 M IE 148 2 recovered
17 85 M IE 150 3 expired
18 295 F LE Lymphangiectasia 28 0 recovered
19 700 M LE Lymphangiectasia 27 0 recovered
20 400 F LE Lymphangiectasia 63 0 recovered
21 720 M LE Lymphangiectasia 88 0 recovered
22 21 M LE Lymphangiectasia 152 0 persistent diarrhea
23 725 F LE Lymphangiectasia 151 0 persistent diarrhea
24 7 M UC 90 0 recovered
25 180 M UC 149 1 recovered
Table 1. Clinical features and outcomes observed in 25 patients with protracted diarrhea
TPN: total parenteral nutrition, ED: epithelial dysplasia group, IE: immune enteropathy group, LE: lymphangiectasia group, UC: unclassified, MVID:
microvillous inclusion disease, IT: intestinal transplantation.
Fig. 2. Age of onset of protracted diarrhea in 25 patients. 
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dysplasia group showed diarrhea starting during the first
week of life. However, the median age of diarrhea onset was
87 days (between 25 and 457 days) in the immune entero-
pathy group and 550 days (between 25 and 725 days) in the
lymphangiectasia group. Eighty percent of patients showed
an onset of diarrhea before one year of age. The onset time of
unclassified two cases were 7 days and 180 days each. The
median duration of PN in the epithelial dysplasia group was
61 days (between 28 and 360 days). Except two patients
who were still alive at the end of this study, the reasons for
the discontinuation of PN were deaths. The median durations
of PN in the immune enteropathy group and lymphangiec-
tasia group were 29 days (between 15 and 150 days) and 63
days (between 27 and 152 days), respectively. The unclassi-
fied two patients received PN for 90 days and 149 days each.
Information concerning siblings was provided in all fami-
lies; in three families (two families with microvillous inclu-
sion disease and one family with immune enteropathy), there
was a sibling died of intractable diarrhea within the first
months of his/her life. Therefore, evidence of familial condi-
tion was present in 3 (12%) of 25 families.
Treatments included: Total PN (100%), cholestyramine
(76%), and steroids (40%), alone or in combination. Twenty
patients survived. Among them, 16 (80%) recovered and 3
(15%) still had diarrhea at the end of this study. These three
patients consisted of two patients with primary lymphangi-
ectasia and one patient with microvillous inclusion disease.
One baby underwent intestinal transplantation for tufting
enteropathy after one year of total PN treatment. The remain-
ing five patients who died were three patients with micro-
villous inclusion disease and two patients with immune ente-
ropathy.
DISCUSSION
The spectrum of PD has changed greatly over the past few
decades (8, 12-15). The increased number of some entero-
pathies, such as microvillous inclusion disease and tufting
enteropathy are certainly related to the wider application of
sophisticated diagnostic investigations, such as transmission
electron microscopic study of the small bowel biopsy speci-
men and identification of ultrastructural abnormalities of
intestinal epithelial cells. An attempt to classify intractable
diarrhea according to villous atrophy was made on the basis
of immunohistochemical and clinicopathologic criteria (7-9).
In a multicenter European study (8), the PD was divided
into two groups (group I and group II), where group I rep-
resented the prominent mucosal atrophy and group II showed
minimal mucosal atrophy with dysplasia. In the present study,
we referred to group I as ‘immune enteropathy group’ because
it has been suggested that the specific histological findings
(in terms of villous atrophy, crypt hyperplasia, and cellular
infiltration of the lamina propria) be associated with a T-cell
activation mechanism (8, 16-20). Group II was referred to
as ‘epithelial dysplasia group’ by adding microvillous inclu-
sion disease, microvillous dysplasia, and microvillous atro-
phy to this group, because this represented histological dys-
plasia and familial conditions seen in group II in European
study (3, 15, 21-24). In a recent study, 29% of children affect-
ed by intractable diarrhea with persistent villous atrophy
(immune enteropathy group) fulfilled the criteria of autoim-
mune enteropathy (8). In 1982, Walker-Smith et al. (6) first
described circulating autoantibodies against the gut epithe-
lium in an 18-month-old boy with chronic diarrhea, failure
to thrive, and small intestinal enteropathy. Since then, sev-
eral additional cases of autoimmune enteropathy have been
reported (25-28). Although we could not finely make the
diagnosis of autoimmune enteropathy because of the lack of
diagnostic modalities including gut epithelial cell autoanti-
bodies (6, 25, 28-32), at least some of the patients in this
study might have had autoimmune enteropathy because all
cases in the epithelial dysplasia group were unresponsive to
elemental milk, dependent on PN, and had considerable
villous atrophy. Epithelial dysplasia group included patients
with severe intractable diarrhea with normal to minimal
villous atrophy with epithelial dysplasia. These cases pre-
sented during the neonatal period (median onset 5 days)
with severe watery diarrhea. A considerable proportion (2 of
5 families) of the patients had affected siblings who had
died within the first month of life with severe diarrhea of
unknown origin. Abnormalities were localized mainly in
the epithelium and showed a similar appearance with those
described as “tufting enteropathy”by Reifen et al. (4). In
some infants with tufting enteropathy, abnormal laminin
and heparin sulfate proteoglycan deposition on basement
membrane has been reported, i.e., faint and irregular laminin
deposition at the epithelial-lamina propria interface, while
heparin sulfate proteoglycan appeared widened and lamellar
(5). Basement membrane molecules are involved in epithe-
lial-mesenchymal cell interactions, which are instrumental
in intestinal development and differentiation (33, 34). The
patient with tufting enteropathy reported here is the first
case in Korea. Finally the patient had to undergo intestinal
transplantation after treatment with PN for over one year.
Microvillous atrophy/inclusion disease can be recognized
by performing periodic acid-Schiff stain and electron micro-
scopy (3, 10). Four cases of microvillous inclusion disease
included in the epithelial dysplasia group have already been
published (35, 36). Microvillus inclusion disease is different
from other diseases causing congenital diarrhea in which
the ultrastructure of the enterocyte is normal (3, 15, 21-24).
Currently, there is no curative therapy available, and afflicted
patients require lifelong total PN or intestinal transplanta-
tion (37-39). In this study two patients who had protracted
diarrhea could not be classified because they showed normal
to minimal villous atrophy without prominent dysplasia.
The clinical and histological findings of these two patients740 N.S. Beck, I.-S. Kang, Y.-L. Suh
were almost similar with those seen in five patients reported
in the European multicenter study (8). We speculate that
some unknown genetic ultrastructural or biohistological
abnormalities may induce PD in this unclassified group of
patients.
Protracted diarrhea is reported to be a syndrome with a
poor prognosis, with a mortality rate ranging from 5% to
47% (1, 2, 8, 12, 13). This was also true in our study, in
which 5 (20%) of 25 patients with PD died during the fol-
low-up. The poorest prognosis was related to congenital
ultrastructural abnormalities of the enterocytes that were
found in three out of five patients who died. For these cases
the only possible treatment at present is long-term PN or
small bowel transplantation. The patient with tufting entero-
pathy included in the epithelial dysplasia group in this study
underwent intestinal transplantation.
In summary, the patients in this study presented as clear-
ly two different histological groups: one group is assumed
to be related to immune mechanism and the other to some
kinds of epithelial anomalies. Interestingly, the less promi-
nent the villous atrophy is the more possible the epithelial
anomaly is like as tufting enteropahty or microvillous inclu-
sion disease. Therefore, if an infant with PD shows minimal
villous changes in duodenal biopsies, an in-depth histologi-
cal review and electron microscopy are mandatory.
This study showed that PD is a rare but daunting problem
in Korea. Advanced diagnostic facilities including histolog-
ical analysis are important for the diagnosis of the underly-
ing diseases. For this reason, we believe that infants with PD
should be promptly referred to specialized centers where an
in-depth diagnostic and therapeutic evaluations are possible.
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